MediWound (MDWD) Gross Margin (2014 - 2025)

MediWound's (MDWD) quarterly Gross Margin came in at 14.89% in Q4 2025, down 57.0% year-on-year from 34.63% in Q4 2024, and down 9.78% quarter-over-quarter from 16.5% in Q3 2025.

MediWound (MDWD) Gross Margin (2014 - 2025) Analysis & Trends

MediWound's Gross Margin history runs 12 years deep, the most recent figure standing at 14.89% for Q4 2025.

  • On a quarterly basis, Gross Margin fell 57.0% year-over-year to 14.89% in Q4 2025; TTM through Dec 2025 was 25.02%, a 926.0% increase from a year earlier, with the FY2025 full-year figure at 19.19%, up 616.0% from the prior year.
  • Gross Margin declined to 14.89% in Q4 2025 per MDWD's latest filing, from 16.5% in the prior quarter.
  • Across five years, Gross Margin topped out at 95.95% in Q1 2021 and bottomed at 12.23% in Q1 2024.
  • The 5-year median for Gross Margin is 28.37% (2021), against an average of 43.45%.
  • Across the five-year window, Gross Margin soared 6823 bps in 2021 and tumbled 6559 bps in 2024, its largest moves.
  • Year by year, Gross Margin stood at 28.05% in 2021, then surged by 150 bps to 70.22% in 2022, then plunged by 81 bps to 13.47% in 2023, then climbed by 15 bps to 15.46% in 2024, then decreased by 4 bps to 14.89% in 2025.
  • Per Business Quant, the three latest MDWD Gross Margin figures stand at 14.89% (Q4 2025), 16.5% (Q3 2025), and 76.51% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 88.95%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 86.85%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 91.79%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 90.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 MediWound 183.16 Mn 178.36 Mn 278,000.00 14.89%

Historic Data

Download Data
DateValue
Dec 31, 2025 14.89%
Sep 30, 2025 16.50%
Jun 30, 2025 76.51%
Mar 31, 2025 18.66%
Dec 31, 2024 15.46%
Sep 30, 2024 15.55%
Jun 30, 2024 28.69%
Mar 31, 2024 12.23%
Dec 31, 2023 13.47%
Sep 30, 2023 18.76%
Jun 30, 2023 94.28%
Mar 31, 2023 21.74%
Dec 31, 2022 70.22%
Sep 30, 2022 41.94%
Jun 30, 2022 66.69%
Mar 31, 2022 33.13%
Dec 31, 2021 28.05%
Sep 30, 2021 92.85%
Jun 30, 2021 93.43%
Mar 31, 2021 95.95%